BRISTOL-MYERS SQUIBB COMPANY Share-based Payment Arrangement, Expense, Tax Benefit
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Share-based Payment Arrangement, Expense, Tax Benefit of $28.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, expense, tax benefit for the quarter ending 2026-06-30 was $28.00M, a 3.45% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, expense, tax benefit for the quarter ending 2026-03-31 was $30.00M, a 0.00% change year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, expense, tax benefit for the quarter ending 2025-12-31 was $27.00M, a 3.85% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, expense, tax benefit for the quarter ending 2025-09-30 was $29.00M, a 7.41% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, expense, tax benefit for fiscal 2025 was $115.00M, a 6.48% increase from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, expense, tax benefit for fiscal 2024 was $108.00M, a 2.86% increase from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, expense, tax benefit for fiscal 2023 was $105.00M, a 15.38% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, expense, tax benefit for fiscal 2022 was $91.00M, a 24.17% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.00M 10-Q · filed 2026-07-30 | $58.00M 10-Q · filed 2026-07-30 | $85.00M derived: sum of 3 quarters · filed 2026-07-30 | $114.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $30.00M 10-Q · filed 2026-04-30 | $57.00M derived: sum of 2 quarters · filed 2026-04-30 | $86.00M derived: sum of 3 quarters · filed 2026-04-30 | $115.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $56.00M derived: sum of 2 quarters · filed 2026-02-11 | $85.00M derived: sum of 3 quarters · filed 2026-07-30 | $115.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $29.00M 10-Q · filed 2025-10-30 | $58.00M derived: sum of 2 quarters · filed 2026-07-30 | $88.00M 10-Q · filed 2025-10-30 | $114.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $29.00M 10-Q · filed 2026-07-30 | $59.00M 10-Q · filed 2026-07-30 | $85.00M derived: sum of 3 quarters · filed 2026-07-30 | $112.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $30.00M 10-Q · filed 2026-04-30 | $56.00M derived: sum of 2 quarters · filed 2026-04-30 | $83.00M derived: sum of 3 quarters · filed 2026-04-30 | $110.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $53.00M derived: sum of 2 quarters · filed 2026-02-11 | $80.00M derived: sum of 3 quarters · filed 2026-02-11 | $108.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | $27.00M 10-Q · filed 2025-10-30 | $54.00M derived: sum of 2 quarters · filed 2025-10-30 | $82.00M 10-Q · filed 2025-10-30 | $107.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $27.00M 10-Q · filed 2025-07-31 | $55.00M 10-Q · filed 2025-07-31 | $80.00M derived: sum of 3 quarters · filed 2026-02-11 | $108.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $28.00M 10-Q · filed 2025-04-24 | $53.00M derived: sum of 2 quarters · filed 2026-02-11 | $81.00M derived: sum of 3 quarters · filed 2026-02-11 | $108.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $53.00M derived: sum of 2 quarters · filed 2026-02-11 | $80.00M derived: sum of 3 quarters · filed 2026-02-11 | $105.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | $28.00M 10-Q · filed 2024-10-31 | $55.00M derived: sum of 2 quarters · filed 2024-10-31 | $80.00M 10-Q · filed 2024-10-31 | $104.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $27.00M 10-Q · filed 2024-07-26 | $52.00M 10-Q · filed 2024-07-26 | $76.00M derived: sum of 3 quarters · filed 2025-02-12 | $99.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $25.00M 10-Q · filed 2024-04-25 | $49.00M derived: sum of 2 quarters · filed 2025-02-12 | $72.00M derived: sum of 3 quarters · filed 2025-02-12 | $94.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $47.00M derived: sum of 2 quarters · filed 2025-02-12 | $69.00M derived: sum of 3 quarters · filed 2025-02-12 | $91.00M 10-K · filed 2025-02-12 |
| 2022-09-30 | $23.00M 10-Q · filed 2023-10-26 | $45.00M derived: sum of 2 quarters · filed 2023-10-26 | $67.00M 10-Q · filed 2023-10-26 | $94.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $22.00M 10-Q · filed 2023-07-27 | $44.00M 10-Q · filed 2023-07-27 | $71.00M derived: sum of 3 quarters · filed 2024-02-13 | $100.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $22.00M 10-Q · filed 2023-04-27 | $49.00M derived: sum of 2 quarters · filed 2024-02-13 | $78.00M derived: sum of 3 quarters · filed 2024-02-13 | $111.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $56.00M derived: sum of 2 quarters · filed 2024-02-13 | $89.00M derived: sum of 3 quarters · filed 2024-02-13 | $120.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | $29.00M 10-Q · filed 2022-10-26 | $62.00M derived: sum of 2 quarters · filed 2022-10-26 | $93.00M 10-Q · filed 2022-10-26 | $127.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $33.00M 10-Q · filed 2022-07-27 | $64.00M 10-Q · filed 2022-07-27 | $98.00M derived: sum of 3 quarters · filed 2023-02-14 | $136.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $31.00M 10-Q · filed 2022-04-29 | $65.00M derived: sum of 2 quarters · filed 2023-02-14 | $103.00M derived: sum of 3 quarters · filed 2023-02-14 | $143.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $72.00M derived: sum of 2 quarters · filed 2023-02-14 | $112.00M derived: sum of 3 quarters · filed 2023-02-14 | $158.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | $38.00M 10-Q · filed 2021-10-27 | $78.00M derived: sum of 2 quarters · filed 2021-10-27 | $124.00M 10-Q · filed 2021-10-27 | $182.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $40.00M 10-Q · filed 2021-07-28 | $86.00M 10-Q · filed 2021-07-28 | $144.00M derived: sum of 3 quarters · filed 2022-02-09 | $154.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $46.00M 10-Q · filed 2021-04-29 | $104.00M derived: sum of 2 quarters · filed 2022-02-09 | $114.00M derived: sum of 3 quarters · filed 2022-02-09 | $123.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $58.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $68.00M derived: sum of 2 quarters · filed 2022-02-09 | $77.00M derived: sum of 3 quarters · filed 2022-02-09 | $87.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $10.00M 10-Q · filed 2020-11-05 | $19.00M derived: sum of 2 quarters · filed 2020-11-05 | $29.00M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $9.00M 10-Q · filed 2020-08-06 | $19.00M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $10.00M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $41.00M 10-K · filed 2021-02-10 | |||
| 2017-12-31 | $59.00M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $35.00M derived: sum of 2 quarters · filed 2019-02-25 | $54.00M derived: sum of 3 quarters · filed 2019-02-25 | $69.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | $16.00M 10-Q · filed 2016-10-27 | $35.00M derived: sum of 2 quarters · filed 2016-10-27 | $50.00M 10-Q · filed 2016-10-27 | $69.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $19.00M 10-Q · filed 2016-07-28 | $34.00M 10-Q · filed 2016-07-28 | $53.00M derived: sum of 3 quarters · filed 2018-02-13 | $73.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $15.00M 10-Q · filed 2016-04-28 | $34.00M derived: sum of 2 quarters · filed 2018-02-13 | $54.00M derived: sum of 3 quarters · filed 2018-02-13 | $74.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $39.00M derived: sum of 2 quarters · filed 2018-02-13 | $59.00M derived: sum of 3 quarters · filed 2018-02-13 | $77.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $20.00M 10-Q · filed 2016-10-27 | $40.00M derived: sum of 2 quarters · filed 2016-10-27 | $58.00M 10-Q · filed 2016-10-27 | $80.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | $20.00M 10-Q · filed 2016-07-28 | $38.00M 10-Q · filed 2016-07-28 | $60.00M derived: sum of 3 quarters · filed 2017-02-21 | $76.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | $18.00M 10-Q · filed 2016-04-28 | $40.00M derived: sum of 2 quarters · filed 2017-02-21 | $56.00M derived: sum of 3 quarters · filed 2017-02-21 | $73.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $38.00M derived: sum of 2 quarters · filed 2017-02-21 | $55.00M derived: sum of 3 quarters · filed 2017-02-21 | $71.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | $16.00M 10-Q · filed 2015-10-27 | $33.00M derived: sum of 2 quarters · filed 2015-10-27 | $49.00M 10-Q · filed 2015-10-27 | $66.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $17.00M 10-Q · filed 2015-07-23 | $33.00M 10-Q · filed 2015-07-23 | $50.00M derived: sum of 3 quarters · filed 2016-02-12 | $63.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $16.00M 10-Q · filed 2015-04-28 | $33.00M derived: sum of 2 quarters · filed 2016-02-12 | $46.00M derived: sum of 3 quarters · filed 2016-02-12 | $64.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $30.00M derived: sum of 2 quarters · filed 2016-02-12 | $48.00M derived: sum of 3 quarters · filed 2016-02-12 | $64.00M 10-K · filed 2016-02-12 |
| 2013-09-30 | $13.00M 10-Q · filed 2014-10-24 | $31.00M derived: sum of 2 quarters · filed 2014-10-24 | $47.00M 10-Q · filed 2014-10-24 | $63.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $18.00M 10-Q · filed 2014-07-24 | $34.00M 10-Q · filed 2014-07-24 | $50.00M derived: sum of 3 quarters · filed 2015-02-13 | $88.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $16.00M 10-Q · filed 2014-04-29 | $32.00M derived: sum of 2 quarters · filed 2015-02-13 | $70.00M derived: sum of 3 quarters · filed 2015-02-13 | $84.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $54.00M derived: sum of 2 quarters · filed 2015-02-13 | $68.00M derived: sum of 3 quarters · filed 2015-02-13 | $82.00M 10-K · filed 2015-02-13 |
| 2012-09-30 | $38.00M 10-Q · filed 2013-10-23 | $52.00M derived: sum of 2 quarters · filed 2013-10-23 | $66.00M 10-Q · filed 2013-10-23 | $81.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | $14.00M 10-Q · filed 2013-07-25 | $28.00M 10-Q · filed 2013-07-25 | $43.00M derived: sum of 3 quarters · filed 2014-02-14 | $56.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | $14.00M 10-Q · filed 2013-04-25 | $29.00M derived: sum of 2 quarters · filed 2014-02-14 | $42.00M derived: sum of 3 quarters · filed 2014-02-14 | $57.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2011-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $28.00M derived: sum of 2 quarters · filed 2014-02-14 | $43.00M derived: sum of 3 quarters · filed 2014-02-14 | $56.00M 10-K · filed 2014-02-14 |
| 2011-09-30 | $13.00M 10-Q · filed 2012-10-24 | $28.00M derived: sum of 2 quarters · filed 2012-10-24 | $41.00M 10-Q · filed 2012-10-24 | $57.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $15.00M 10-Q · filed 2012-07-25 | $28.00M 10-Q · filed 2012-07-25 | $44.00M derived: sum of 3 quarters · filed 2013-02-15 | $60.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $13.00M 10-Q · filed 2012-04-26 | $29.00M derived: sum of 2 quarters · filed 2013-02-15 | $45.00M derived: sum of 3 quarters · filed 2013-02-15 | $61.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $32.00M derived: sum of 2 quarters · filed 2013-02-15 | $48.00M derived: sum of 3 quarters · filed 2013-02-15 | $63.00M 10-K · filed 2013-02-15 |
| 2010-09-30 | $16.00M 10-Q · filed 2011-10-27 | $32.00M derived: sum of 2 quarters · filed 2011-10-27 | $47.00M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $16.00M 10-Q · filed 2011-07-28 | $31.00M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $15.00M 10-Q · filed 2011-04-28 | |||
| 2009-12-31 | $60.00M 10-K · filed 2012-02-17 | |||
| 2008-12-31 | $59.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |